GLP1R and Alzheimer disease: AD is a progressive and irreversible neurodegenerative disorder characterized by an unclear etiology and pathogenesis.424 In AD, GLP-1(7-36) amide inhibits IL-1β transcription and prevents cognitive dysfunction, amyloid precursor protein synthesis, and cell death.